KLDO

Kaleido Biosciences, Inc. Common Stock
KLDO

Delisted

KLDO was delisted on the 14th of April, 2022.

Back to rankings
 

About: Kaleido Biosciences Inc is a clinical-stage healthcare company. It is focused on leveraging the potential of the microbiome organ to treat disease and improve human health. Its product candidates are Microbiome Metabolic Therapies, or MMTs, which are designed to modulate the metabolic output and profile of the microbiome.

Employees: 76

Healthcare Drug Manufacturers - General
Charts implemented using Lightweight Charts™